Overview
Sarah Gooding practices practicing medicine in Oxford, United Kingdom.
Ms. Gooding is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Multiple Myeloma, Severe Acute Respiratory Syndrome (SARS), COVID-19, and Monoclonal Gammopathy of Undetermined Significance (MGUS).
She is actively involved in clinical research, co-authoring 42 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Sarah Gooding
Is Sarah Gooding a top-rated expert for Multiple Myeloma?
MediFind is an objective health platform that identifies experts based on real-world data. Sarah Gooding is classified as an Distinguished expert for Multiple Myeloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Sarah Gooding participate in research or clinical trials?
Yes. Sarah Gooding has published 42 articles and abstracts on conditions like Multiple Myeloma. You can view a list of Sarah Gooding's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Multiple MyelomaMs. Gooding isDistinguished. Learn about Multiple Myeloma.
- Experienced
- COVID-19Ms. Gooding isExperienced. Learn about COVID-19.
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Severe Acute Respiratory Syndrome (SARS)Ms. Gooding isExperienced. Learn about Severe Acute Respiratory Syndrome (SARS).